Matt Lavietes | NBC News
Guest
Offline
As policymakers around the world debate whether minors should have access to transition-related medications, a study published Monday in the nation’s premier pediatric medical journal found that the drugs are rarely prescribed to youths, NBC News reports.
Less than 0.1% of adolescents with private insurance in the United States are transgender or gender-diverse and are prescribed puberty blockers or gender-affirming hormones, according to the findings published in JAMA Pediatrics.
The research note, which analyzed the private insurance claims for...
Continue reading...